New Deal
David Kirn
Chairman and CEO at 4D MOLECULAR THERAPEUTICS
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (1)
Key Relationships
Announcement Date
Deal Value
4d Molecular Therapeutics
Mirae Asset Financial Group
£56m
11 dealmakers